Skip to main content

Prevalite Side Effects

Generic name: cholestyramine

Medically reviewed by Drugs.com. Last updated on Dec 26, 2023.

Note: This document provides detailed information about Prevalite Side Effects associated with cholestyramine. Some dosage forms listed on this page may not apply specifically to the brand name Prevalite.

Applies to cholestyramine: oral powder for suspension.

In some animal studies, cholestyramine (the active ingredient contained in Prevalite) was found to cause tumors. It is not known whether cholestyramine causes tumors in humans.

Serious side effects of Prevalite

Along with its needed effects, cholestyramine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking cholestyramine:

Rare side effects

  • black, tarry stools
  • stomach pain (severe) with nausea and vomiting
  • loss of weight (sudden)

Check with your doctor as soon as possible if any of the following side effects occur while taking cholestyramine:

More common side effects

Other side effects of Prevalite

Some side effects of cholestyramine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

  • heartburn or indigestion
  • nausea or vomiting
  • stomach pain

Less common side effects

  • belching
  • bloating
  • diarrhea
  • dizziness
  • headache

For healthcare professionals

Applies to cholestyramine: compounding powder, oral powder for reconstitution.

General adverse events

The most frequently reported side effect is constipation.[Ref]

Gastrointestinal

Intestinal obstruction occurred rarely and 2 deaths in pediatric patients were reported.[Ref]

Cardiovascular

Musculoskeletal

Hematologic

Metabolic

Dermatologic

Hepatic

Nervous system

Other

Ocular

Genitourinary

Respiratory

Psychiatric

References

1. (2002) "Product Information. Questran (cholestyramine)." Par Pharmaceutical Inc

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. Cerner Multum, Inc. "Australian Product Information."

4. (2017) "Product Information. Cholestyramine Light (cholestyramine)." Sandoz Laboratories, Eon Division

Further information

Prevalite side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.